ArticleThe Journal of experimental medicine2021

Preclinical validation of a potent γ-secretase modulator for Alzheimer's disease prevention.

Kevin D Rynearson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.